MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

about

Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research.Molecular processes involved in B cell acute lymphoblastic leukaemia.

P2860

Q38679992-9FE69562-6A8D-4816-8972-912D180C1D31 Q48218289-50E830EB-7D0B-41F7-880A-0F405F0CAA9D

P2860

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

Item

http://www.wikidata.org/entity/Q37676956

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

@en

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.

@nl

type

Item

label

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

@en

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.

@nl

prefLabel

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

@en

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.

@nl

P1476

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

@en

P2093

Emmanouela Repapi

http://www.w3.org/2001/XMLSchema#string

Erica Ballabio

http://www.w3.org/2001/XMLSchema#string

Huimin Geng

http://www.w3.org/2001/XMLSchema#string

Jim R Hughes

http://www.w3.org/2001/XMLSchema#string

Jon Kerry

http://www.w3.org/2001/XMLSchema#string

Marina Konopleva

http://www.w3.org/2001/XMLSchema#string

Marta Tapia

http://www.w3.org/2001/XMLSchema#string

Ross Thorne

http://www.w3.org/2001/XMLSchema#string

P2860

CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis

Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer

SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

The Sequence Alignment/Map format and SAMtools

The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure

STAR: ultrafast universal RNA-seq aligner

Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.

ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.

P304

64-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPHEM.2016.11.003

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas A Milne

James O. Davies

Laura Godfrey

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27856324

http://www.w3.org/2001/XMLSchema#string

P932

5333536

http://www.w3.org/2001/XMLSchema#string

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

about

P2860

P2860

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932